trial

Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression

NCTId NCT07057024
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 120 (estimated)
Sponsored by Etablissement Public de Santé Barthélemy Durand
Primary completion 2028-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2026-02-12
Primary completion
2028-02
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Clinical and eye movements

Sponsors

Etablissement Public de Santé Barthélemy DurandLead Sponsor
Aix Marseille UniversitéCollaborator
Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
Hopital Paul BrousseCollaborator

Investigators

1
Eric ArtigesPrincipal Investigator

Sites

1 total
Étampes, France

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2028-02
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Clinical and eye movements
drug
lead_sponsor
Etablissement Public de Santé Barthélemy Durand
company
collaborator
Aix Marseille Université
company
Institut National de la Santé Et de la Recherche Médicale, France
company
indication
Bipolar Disorder
indication
Psychiatric Disorders (Diagnosis)
indication
Schizophrenia
indication
investigator
Eric Artiges
person